Indication

Nosocomial bacterial pneumonia

Nosocomial bacterial pneumonia is an acute infection of the lower respiratory tract parenchymal tissue acquired in an inpatient healthcare setting, typically defined by the onset of symptoms 48 hours or more following hospital admission that were not incubating upon entry. Read more about Nosocomial bacterial pneumonia

72 drugs 49 manufacturers

Advertisement

Drugs that treat it

Common Nosocomial bacterial pneumonia therapies.

Showing 10–18 of 72 drugs

Filter & compare in the drug finder →Opens the drug finder with Nosocomial bacterial pneumonia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Nosocomial bacterial pneumonia.

Nosocomial bacterial pneumonia is an acute infection of the lower respiratory tract parenchymal tissue acquired in an inpatient healthcare setting, typically defined by the onset of symptoms 48 hours or more following hospital admission that were not incubating upon entry.

It primarily affects hospitalized individuals, particularly critically ill, elderly, immunocompromised, or mechanically ventilated patients.

Pathophysiologically, the condition commonly arises when colonized pathogenic bacteria—frequently multidrug-resistant Gram-negative bacilli such as *Pseudomonas aeruginosa* or Gram-positive cocci such as *Staphylococcus aureus*—are microaspirated from the oropharynx into the pulmonary alveoli, overwhelming host immune defenses.

Clinically, it presents with new or progressive pulmonary infiltrates on chest imaging accompanied by systemic and respiratory features, including fever, leukocytosis or leukopenia, purulent sputum production, and worsening hypoxemia.

Personalize your experience

Follow Nosocomial bacterial pneumonia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it